Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Houchin, Erin [R-IN-9]

Rep. Houchin, Erin [R-IN-9]

United States · Official source

Records

561 records where Rep. Houchin, Erin [R-IN-9] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 7008 (119th)open

Stop Insider Trading Act

United States · United States Congress · 12 January 2026

Stop Insider Trading Act This bill generally prohibits Members of Congress and their spouses and dependent children from purchasing stocks and requires public notice before these individuals may sell stocks. Specifically, Members of Congress and the spouses and dependent children of Members of Congress may not purchase covered investments. Between 7 and 14 days before a Member or a covered spouse or dependent sells a covered investment, the relevant Member must file public notice of the intent to sell with the Clerk of the House of Representatives or the Secretary of the Senate, as appropriate. The Clerk or Secretary must publish this notice online. If the individual decides not to sell the covered investment, the notice must be withdrawn. Under the bill, a covered investment is a security issued by a publicly traded company or a comparable economic interest. Some investments are exempt, including interest in a widely held investment fund and certain investments held in a trust. Violations of these provisions are subject to a fee and, in the case of a purchase, a requirement to sell the covered investment. The fee must equal (1) the greater of $2,000 or 10% of the transaction value, and (2) any net gain realized from the transaction during a specified period. The fee may not be paid using campaign donations or Members’ official allowances. Certain transactions by covered spouses and dependents are exempt, including transactions made on behalf of another person or made as part of compensation from the individual’s employer.

Resolution· HRESH.Res. 977 (119th)passed

Providing for consideration of the bill (H.R. 4593) to amend the Energy Policy and Conservation Act to revise the definition of showerhead; providing for consideration of the bill (H.R. 5184) to prohibit the Secretary of Energy from enforcing energy efficiency standards applicable to manufactured housing, and for other purposes; and providing for consideration of the bill (H.R. 6938) making consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes.

United States · United States Congress · 7 January 2026

This resolution provides for the consideration of the bill (H.R. 4593) to amend the Energy Policy and Conservation Act to revise the definition of showerhead; providing for consideration of the bill (H.R. 5184) to prohibit the Secretary of Energy from enforcing energy efficiency standards applicable to manufactured housing, and for other purposes; and providing for consideration of the bill (H.R. 6938) making consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes.

Resolution· HRESH.Res. 981 (119th)referred

Expressing the sense of the House of Representatives that the United States should reduce and maintain the Federal unified budget deficit at or below 3 percent of gross domestic product.

United States · United States Congress · 7 January 2026

This resolution expresses the sense of the House of Representatives that (1) Congress should adopt a fiscal target to reduce the federal budget deficit to 3% of gross domestic product or less as soon as possible and no later than the end of FY2030; and (2) after the target is achieved, Congress should continue to pursue further deficit reduction with the goal of achieving a balanced federal budget.

Bill· HRH.R. 6509 (119th)referred

SAFE Drugs Act of 2025

United States · United States Congress · 9 December 2025

Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2025 or the SAFE Drugs Act of 2025 This bill provides for increased oversight of drug compounding and imposes statutory limits on compounded drugs that are essentially copies of commercially available drugs. Currently, subject to certain requirements, compounded drugs (i.e., drugs that are mixed or altered to meet patient needs) do not require Food and Drug Administration (FDA) approval. Additional limits apply to the compounding of drugs that are essentially copies of commercially available drug products. Under the bill, a compounded drug is essentially a copy of a commercially available drug product if (1) the compounded drug contains any active ingredient found in a commercially available drug product, and (2) there is no change made for an individual patient that results in a significant difference between the compounded drug and the commercially available drug. (The FDA’s current definition of the term also addresses dosage strength and route of administration.)  The bill increases the frequency at which a licensed pharmacist or physician may compound a drug that is essentially a copy of a commercially available drug to 20 times per month. Current FDA policy allows four such prescriptions per month. The bill also imposes annual reporting requirements on physicians, facilities, and pharmacies (except hospital-based pharmacies) that compound certain drug products for out-of-state patients more than 20 times per month. Further, the bill subjects certain large-scale outsourcing facilities (i.e., FDA-registered facilities that compound in bulk) to regular inspection and reporting requirements.

Bill· HRH.R. 6489 (119th)open

SAFE BOTs Act

United States · United States Congress · 5 December 2025

Bill· HRH.R. 6488 (119th)referred

RESET Act

United States · United States Congress · 5 December 2025

Bill· HRH.R. 6392 (119th)open

Home School Graduation Recognition Act

United States · United States Congress · 3 December 2025

Home School Graduation Recognition Act This bill clarifies that students who complete their secondary education in a home school setting recognized under state law are high school graduates for purposes of eligibility for federal student aid.

Bill· HRH.R. 6207 (119th)referred

Chip EQUIP Act

United States · United States Congress · 20 November 2025

Bill· HRH.R. 6143 (119th)referred

PRECISE Act

United States · United States Congress · 19 November 2025

Producing Responsible Energy and Conservation Incentives and Solutions for the Environment Act or the PRECISE Act This bill incorporates support for precision agriculture into various programs of the Department of Agriculture (USDA). Precision agriculture refers to managing, tracking, or reducing crop or livestock production inputs, including seed, feed, fertilizer, chemicals, water, and time, at a heightened level of spatial and temporal granularity to improve efficiencies, reduce waste, and maintain environmental quality. Precision agriculture technology includes any technology and equipment that directly contributes to a reduction in, or improved efficiency of, inputs used in crop or livestock production. Specifically, the bill makes changes to eligibility criteria, payments, and other aspects of the Conservation Loan Program, the Environmental Quality Incentives Program, and the Conservation Stewardship Program. These changes include allowing the programs to support the adoption of precision agriculture practices and acquisition of precision agriculture technologies. In addition, the bill expands a program through which USDA makes and insures loans to for-profit and nonprofit organizations that invest in rural areas by allowing the loans to be used for precision agriculture practices. Also, USDA must emphasize the use of third-party providers when providing technical assistance related to soil health for participants in certain USDA conservation programs. This includes planning related to the use of cover crops, precision agriculture practices, and comprehensive nutrient management.

Bill· HRH.R. 6019 (119th)open

To repeal certain provisions relating to notification to Senate offices regarding legal process on disclosure of Senate data, and for other purposes.

United States · United States Congress · 12 November 2025

This bill repeals the authority for a Senator to bring a civil action against the federal government if an internet service provider or the Senate Sergeant at Arms (SAA) accessed or disclosed, or accesses or discloses, data from the Senator's office to provide to a federal agency without following prescribed notice requirements. The authority applies to a qualifying instance occurring on or after January 1, 2022.  The authority for the civil action was enacted in H.R. 5371, the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 , which was signed by the President on November 12, 2026. The relevant provision requires written notice from the internet service provider or the SAA to the Senate office upon receipt of any legal process seeking access or disclosure of covered data. A Senator affected by a federal violation of the provision may sue the federal government for the greater of $500,000 per violation or the actual damages, plus attorney's fees and related costs.

Bill· HRH.R. 5629 (119th)referred

To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.

United States · United States Congress · 30 September 2025

This bill nullifies part of the final rule issued by the Department of Health and Human Services (HHS) titled Medications for the Treatment of Opioid Use Disorder and published on February 2, 2024. The rule incorporated into regulations certain flexibilities for opioid treatment that were initially implemented during the COVID-19 public health emergency. The bill nullifies these flexibilities, including (1) expanded flexibility for patients in their first or second month of treatment to receive take-home doses of methadone, (2) flexibility to use telehealth examinations to admit patients for treatment involving buprenorphine or methadone, and (3) expanded access to evidence-based practices such as splitting doses for certain patients.  Pursuant to a statutory requirement, the rule also allowed patients to be admitted to an opioid treatment program without having to show at least a one-year history of opioid misuse. The bill nullifies these provisions of the rule.

Bill· HRH.R. 5616 (119th)open

$2.50 for America’s 250th Act

United States · United States Congress · 30 September 2025

$2.50 for America’s 250th Act This bill requires the minting of $2.50 coins to commemorate the 250th anniversary, or the semiquincentennial, of the signing of the Declaration of Independence. Specifically, the Department of the Treasury must mint and issue a $2.50 circulating coin upon determining that such minting is technically feasible, economically feasible, and not cost prohibitive. The design of such a coin during the first five years of its issuance must be as described by the bill, however, subsequent designs may be selected by Treasury to celebrate the founding of the United States. Treasury may also mint and issue $2.50 numismatic coins (i.e., collectible coins) in silver, clad, and other alloys, including gold.

Bill· HRH.R. 5505 (119th)reported

Equal Campus Access Act of 2025

United States · United States Congress · 18 September 2025

Equal Campus Access Act of 2025 This bill prohibits funding made available under the Higher Education Act of 1965 from being provided to any public institution of higher education (IHE) that denies certain campus rights to religious student organizations. Specifically, the bill prohibits a public IHE from receiving these funds if it denies a religious student organization any right, benefit, or privilege that is otherwise afforded to other student organizations at the IHE because of the religious student organization's beliefs, practices, speech, leadership standards, or standards of conduct.

Bill· HRH.R. 5438 (119th)reported

Incentivize Savings Act

United States · United States Congress · 17 September 2025

Resolution· HRESH.Res. 719 (119th)passed

Honoring the life and legacy of Charles Charlie James Kirk.

United States · United States Congress · 16 September 2025

This resolution (1) condemns the assassination of Charles "Charlie" James Kirk and all forms of political violence; and (2) honors the life, leadership, and legacy of Charlie Kirk.

Bill· HRH.R. 5360 (119th)open

AWARE Act

United States · United States Congress · 15 September 2025

Bill· HRH.R. 5267 (119th)reported

American Franchise Act

United States · United States Congress · 10 September 2025

Bill· HRH.R. 5269 (119th)referred

RESULTS Act

United States · United States Congress · 10 September 2025

Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 or the RESULTS Act This bill requires the use of particular data from the private sector to inform Medicare payment rates for certain widely available laboratory tests.  Specifically, the Centers for Medicare & Medicaid Services (CMS) must contract with an entity that maintains a database of claims data for clinical diagnostic laboratory tests that (1) are not advanced diagnostic tests, and (2) were furnished by more than 100 providers and suppliers of such services over a specified six-month period (i.e., widely available tests). The database must meet specified requirements, such as having data that is representative of the entire country and from more than 50 private payors and claims administrators. The contracted entity must be a nonprofit entity that is not affiliated with any government agency, any insurance issuer or provider, or any other organization in the health care sector.  Beginning January 1, 2028, the CMS must use the information obtained from the database to inform Medicare payment rates for these widely available laboratory tests.  The bill additionally specifies processes for determining payment rates for laboratory tests that are not advanced diagnostic tests, are not widely available, and lack adequate claims data. The CMS must use certain existing processes to set appropriate rates. The bill also delays scheduled payment reductions for laboratory tests until 2028 and allows for judicial and administrative review of payment rates. 

Bill· HRH.R. 5184 (119th)referred

Affordable HOMES Act

United States · United States Congress · 8 September 2025

Affordable Housing Over Mandating Efficiency Standards Act or the Affordable HOMES Act This bill rescinds Department of Energy (DOE) energy efficiency regulations applicable to manufactured housing and eliminates DOE’s authority to issue similar regulations. Specifically, the bill rescinds the DOE final rule titled Energy Conservation Program: Energy Conservation Standards for Manufactured Housing and published on May 31, 2022. Under the bill, DOE may provide recommendations to the Department of Housing and Urban Development for revisions to energy conservation standards applicable to manufactured housing. These recommendations must comply with criteria established by the bill, including by being based on the determination of the cost-effectiveness of such revision.

Resolution· HRESH.Res. 668 (119th)passed

Directing the Committee on Oversight and Government Reform to continue its ongoing investigation into the possible mismanagement of the Federal government’s investigation of Mr. Jeffrey Epstein and Ms. Ghislaine Maxwell, and for other purposes.

United States · United States Congress · 2 September 2025

This resolution directs the Committee on Oversight and Government Reform to continue its investigation into the federal government's investigation of Jeffrey Epstein and Ghislaine Maxwell and to release to the public committee records relating to the committee's investigation, subject to limited exceptions. Under the resolution, the committee records to be publicly disclosed include unclassified records referring or relating to Epstein's detention and death; flight logs of aircraft owned or used by Epstein; individuals named in connection with Epstein’s criminal activities, civil settlements, or immunity or plea agreements; immunity deals, sealed settlements, or plea bargains of Epstein or his associates; entities with ties to Epstein’s trafficking or financial networks; and internal Department of Justice communications concerning decisions to investigate or charge Epstein or his associates. The resolution provides that the committee may withhold or redact portions of records with written justification that such portions contain (1) victims' personally identifiable information; (2) child sexual abuse materials; (3) images of death, physical abuse, or injury; (4) information which would jeopardize an active federal investigation or prosecution; or (5) classified information. The committee may not withhold or redact records on the basis of embarrassment, reputational harm, or political sensitivity. The resolution states support for the committee's subpoenas and investigatory actions and encourages timely compliance with them. Additionally, the committee shall issue investigative reports as it deems necessary.

Bill· HRH.R. 4950 (119th)referred

Data BRIDGE Act

United States · United States Congress · 12 August 2025